WO2016118948A1 - Géométrie de pointe atraumatique pour des dispositifs à demeure - Google Patents

Géométrie de pointe atraumatique pour des dispositifs à demeure Download PDF

Info

Publication number
WO2016118948A1
WO2016118948A1 PCT/US2016/014688 US2016014688W WO2016118948A1 WO 2016118948 A1 WO2016118948 A1 WO 2016118948A1 US 2016014688 W US2016014688 W US 2016014688W WO 2016118948 A1 WO2016118948 A1 WO 2016118948A1
Authority
WO
WIPO (PCT)
Prior art keywords
atraumatic tip
length
tubular structure
indwelling device
bending stiffness
Prior art date
Application number
PCT/US2016/014688
Other languages
English (en)
Inventor
Farokh R. DEMEHRI
Daniel H. Teitelbaum
Jonathan E. Luntz
Brent Utter
Diann Erbschloe BREI
Jennifer Freeman
Original Assignee
The Regents Of The University Of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/718,175 external-priority patent/US10159486B2/en
Application filed by The Regents Of The University Of Michigan filed Critical The Regents Of The University Of Michigan
Priority to EP16740895.4A priority Critical patent/EP3247448A4/fr
Publication of WO2016118948A1 publication Critical patent/WO2016118948A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00—Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02—Dilators made of swellable material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09—Guide wires
    • A61M2025/09175—Guide wires having specific characteristics at the distal tip

Definitions

  • the present disclosure relates to indwelling devices and, more particularly, relates to an atraumatic tip geometry having tapering stiffness allowing for atraumatic placement of an indwelling device inserted in biological tubular structures.
  • Distraction enterogenesis may provide a novel therapy for short bowel syndrome (SBS).
  • SBS short bowel syndrome
  • Previously described methods have relied upon isolated intestinal segments or transmural fixation due to ineffective endoluminal attachment.
  • the present teachings provide a novel approach using geometric coupling between a tapering device and the mesenteric curvature to allow trans-stomal distraction enterogenesis.
  • a catheter device with tapering stiffness was developed, consisting of, in some embodiments, a stiff catheter with a taper to a flexible latex tip to prevent perforation.
  • Yorkshire pigs underwent creation of a jejunal Roux limb with device placed via jejunostomy. Intestinal attachment was achieved without substantial reduction in bowel perfusion as measured by laser Doppler.
  • An external clamp was secured at the stoma to provide external fixation of the device.
  • the catheter was advanced 1 cm/day for either 7 or 14 days before explant.
  • the distracted segment achieved a mean ⁇ SD increase in length of 37 ⁇ 6% versus fed, nondistracted bowel, corresponding to an absolute gain of 10.6 ⁇ 1 .7 cm (1 .5 cm/day).
  • the Roux limb achieved an 80 ⁇ 2% increase in length versus fed control bowel, corresponding to an absolute gain of 16.8 ⁇ 3.0 cm (1 .2 cm/day). No perforation or stoma- related complication occurred.
  • an indwelling device for insertion in a biological tubular structure
  • an elongated device having a body and opposing ends.
  • the body has a bending stiffness transverse to a longitudinal axis that is greater than a stiffness of the biological tubular structure.
  • An atraumatic tip member having a proximal end and a distal end, extends from the end of the elongated device.
  • the proximal end has a first bending stiffness transverse to a longitudinal axis and the distal end has a second bending stiffness transverse to the longitudinal axis, wherein the second bending stiffness being less than the first bending stiffness.
  • FIG. 1 is a perspective view of an indwelling device for distraction enterogenesis having an atraumatic tip geometry according to the principles of the present teachings in a first size position (e.g. deflated);
  • FIG. 2 is a perspective view of the indwelling device for distraction enterogenesis having the atraumatic tip geometry according to the principles of the present teachings in a second size position (e.g. inflated);
  • FIG. 3 is a perspective view of the atraumatic tip geometry according to some embodiments.
  • FIGS. 4A-4E illustrate a series of cross-sectional schematic views of actuation of an elongation system according to the principles of the present teachings
  • FIG. 5 is a side view illustrating the fenestrated decoupling device according to the principles of the present teachings
  • FIG. 6 illustrates the device inserted into a tubular organ where the gradual increase in stiffness with device insertion allows geometric coupling with the mesenteric curvature of the jejunal Roux limb;
  • FIG. 7 illustrates a stoma clamp providing external fixation
  • FIG. 8 illustrates a system for testing the mechanical characterization of the atraumatic tip geometry where weights (W) are hung from the atraumatic tip at a set distance (L) from a v-groove clamp at select points along the atraumatic tip, where the vertical deflection (d) is measured and used to compute the bending stiffness at that point along the tip;
  • FIG. 9 is a graph illustrating the bending stiffness of the atraumatic tip at various distances from the distal end of the atraumatic tip
  • FIG. 10 is a graph illustrating the minimum bending radius of the atraumatic tip before permanent bending measured at select points along the portion of the atraumatic tip;
  • FIG. 1 1 illustrates silastic markers initially placed 3 cm apart demonstrating a significant increase in spacing after 7 days of distraction, wherein the distracted segment (arrow) and fed control (triangle) are shown without tension, with the device removed;
  • FIG. 12 is a graph illustrating the net percentage of growth versus marker number from the stoma to each marker (relative to fed control), with the region of geometric fixation (the first mesenteric curve of the jejunal Roux limb) indicated; and
  • FIG. 13 is a graph illustrating the increase in distance from the stoma to each marker for the distracted segment relative to fed control.
  • Example embodiments will now be described more fully with reference to the accompanying drawings. Example embodiments are provided so that this disclosure will be thorough, and will fully convey the scope to those who are skilled in the art. Numerous specific details are set forth such as examples of specific components, devices, and methods, to provide a thorough understanding of embodiments of the present disclosure. It will be apparent to those skilled in the art that specific details need not be employed, that example embodiments may be embodied in many different forms and that neither should be construed to limit the scope of the disclosure. In some example embodiments, well-known processes, well-known device structures, and well- known technologies are not described in detail.
  • Short bowel syndrome where loss of small bowel length results in insufficient nutrient absorptive capacity for growth and development, is the most common cause of pediatric intestinal failure. Survival among patients with SBS is predicted by the length of the residual small bowel, making the restoration of intestinal length an attractive strategy. Operative lengthening procedures have been developed but carry the risk of complications (e.g., infection, perforation, bleeding, and obstruction) and are limited to patients with favorable anatomy (e.g., dilated small bowel). Small bowel transplantation has been used less frequently in recent years, partially because of less-than-optimal outcomes, with graft failure and rejection approaching 60% at 5 years. Therefore, therapy for SBS consists primarily of supportive therapy with supplemental or total parenteral nutrition, which carries risks of hepatic dysfunction, metabolic derangement, and sepsis.
  • supportive therapy for SBS consists primarily of supportive therapy with supplemental or total parenteral nutrition, which carries risks of hepatic dysfunction, metabolic derangement, and sepsis.
  • Distraction enterogenesis may provide a therapeutic option for the treatment of SBS patients who otherwise face little chance of achieving enteral autonomy.
  • Distraction enterogenesis is the use of mechanical force to induce small bowel lengthening and has been shown in animal models to produce durable increases in length with preservation of intestinal function. Increased intestinal length is accompanied by mesenteric neovascularization, muscular hypertrophy, increased mucosal surface area, and increased epithelial cell proliferation.
  • distraction enterogenesis has shown promise in animal models, it has yet to become a clinically applicable strategy.
  • Previous methods of distraction enterogenesis have been limited by the use of blind- ending intestinal segments or transmural sutures to allow attachment of the device, which is necessary for transmission of mechanical force to the intestinal wall. These methods of attachment require an implant operation to create the blind-ending segments or to place sutures, followed by a second explant operation to restore continuity.
  • the restoration of intestinal continuity may result in the loss of gained intestinal length— up to 39%— because of the need for creation of a new anastomosis.
  • patients with SBS have been shown to mount a postoperative inflammatory response, making multiple intestinal operations a high-risk proposition for such patients.
  • a device and method for distraction enterogenesis employs a fully endoluminal intestinal lengthening device that exerts a lengthening force on an organ.
  • a fully endoluminal intestinal lengthening device that exerts a lengthening force on an organ.
  • the principles of the present teachings are equally applicable to any device that is inserted and/or indwelling within a soft tubular organ or similar bodily feature of a human or animal.
  • the present teachings are particularly well adapted for use in a bowel (i.e. large bowel), esophagus, artery, vein, and the like, and thus the present discussion will be particularly directed thereto.
  • the present teachings obviates the need for surgical placement of the device beyond the creation of an intestinal stoma (gastrostomy or enterostomy), which many patients with SBS already have because of their underlying disease.
  • the use of a novel catheter with progressive reduction in stiffness allows endoluminal small bowel fixation.
  • the geometric intestinal attachment allows distraction and intestinal lengthening via a jejunostomy. Safety and efficacy of this approach are demonstrated in a well-established swine model.
  • a device 10 for example, is provided having an atraumatic tip 12 extending from at least one end thereof.
  • the structure of the atraumatic tip 12 will be described in detail herein.
  • Device 10 can be any device suitable for insertion and/or indwelling within a tubular organ or structure of a human and/or animal (e.g. a biological tubular structure, such as a bowel (i.e. large bowel), esophagus, artery, vein, and the like).
  • a biological tubular structure such as a bowel (i.e. large bowel), esophagus, artery, vein, and the like.
  • device 10 can comprise an elongation system 200.
  • elongation system 200 can be a mechanotransduction enterogenesis device for use in lengthening soft tissue (e.g. bowel). It should be understood, however, that the present disclosure is not to be regarded as requiring an elongation system or other component unless specifically claimed.
  • elongation system 200 can comprise an elongated member or device 202 having a body with opposing ends 204, 206 (i.e. distal and proximal ends). The body can be rigid in a direction transverse to a longitudinal axis (i.e. a bending stiffness) of the body.
  • the body can define a bending stiffness that is greater than the stiffness of the biological tubular structure in which it is inserted and/or indwelling.
  • the body can be generally tubular or define any other shape complementary to the biological tubular structure.
  • one or more of the opposing ends 204, 206 can comprise a fenestrated attachment system 220, which will be described in greater detail herein.
  • elongation system 200 can comprise an extending or actuation mechanism 208 that is operable to longitudinally drive elongation system 200 between an extended position and a retracted position. In the extended position (see FIGS.
  • the opposing ends 204, 206 and the associated fenestrated attachment system 220 define a spaced-apart orientation.
  • the opposing ends 204, 206 and the associated fenestrated attachment system 220 define a spaced-together orientation. In this way, in the retracted position, ends 204, 206 are in their narrowest configuration and, in the extended position, ends 204, 206 are in their widest configuration.
  • both fenestrated attachment systems 220 are engaged with the interior surface 102 of the hollow member 100, movement between the retracted position and the extended position can result in application of a tensile force to the hollow member 100 proportional to the force exerted by extending mechanism 208.
  • movement between the retracted position and the extended position can result in application of a translational force.
  • extending mechanism 208 can comprise a reciprocating linear hydraulic actuator.
  • drive actuation devices can be used in connection with extending mechanism 208, including hydraulic, pneumatic, push-cable driven, screw-driven, SMA wire, SMA helical spring, SMA-driven ratchet, thermal expansion/phase change actuator driven, electromagnetic actuator (solenoid, linear stepper motor, rotary screw drive motor).
  • electromagnetic actuator solenoid, linear stepper motor, rotary screw drive motor.
  • extending mechanism 208 when configured as a reciprocating linear hydraulic actuator, is based on a "payout" approach. By repeating the operation cycle, the length of tissue growth induced is limited only by the number of times extending mechanism 208 is cycled rather than the stroke of extending mechanism 208.
  • extending mechanism 208 can be concealed and/or protected using a sheath 210, such as a thin silicone sheath, to protect extending mechanism 208 from associated environmental contaminants and to facilitate operation. For example, when the device is retracted, the thin silicone sheath prevents the bowel from pleating between the attachments, promoting the repositioning of bowel relative to the attachments.
  • a fenestrated attachment system 220 such as an endoluminal balloon attachment mechanism, is provided that employs a fenestrated decoupling system 222 as illustrated in FIG. 5.
  • the fenestrated attachment system 220 is placed within the bowel lumen or other hollow organ member 100 and is capable of radially expanding, thereby coupling with the inner luminal surface 102 of the bowel or other interior surface 102 of the hollow member 100, to allow transfer of longitudinal tensile loads to the bowel wall or hollow member 100 and/or permit translation therethrough.
  • fenestrated attachment system 220 comprises an expanding device 224 (e.g. balloon) disposed on at least one end 204, 206.
  • expanding device 224 is enlargeable between a deflated position (first size position) and an inflated position (second size position), whereby the inflated position is sufficiently large to permit mechanical engagement with the interior surface 102 of the hollow member 100 (i.e. bowel lumen). It should be understood that in some embodiments, the size of the inflated position must be sufficiently large to further accommodate any resultant enlargement of the hollow member in response to application of the inflation force.
  • the size of the deflated position must be sufficiently smaller to permit disengagement of fenestrated attachment system 220 from the interior surface 102 of hollow member 100, at least when used in conjunction with fenestrated decoupling system 222.
  • fenestrated attachment system 220 further comprises a friction enhancement or texture 226.
  • friction enhancement 226 can comprise application of an abrasive texture generally surrounding expanding device 224 that is capable of expanding during inflation of expanding device 224 and retracting during deflation of expanding device 224.
  • an open-cell matrix such as a 3M, Scotch-Brite Dobie, is useful.
  • friction enhancement 226 can comprise a fabric material structure surrounding expanding device 224.
  • the fabric material structure can include one or more fibers knitted into a series of interlocked loops such that the knitted fabric can expand and contract along with expanding device 224. The loops can engage the interior surface 102 of the hollow member 100.
  • the fibers can include a flat ribbon such that the edges of the flat ribbon engage with the interior surface of the hollow member.
  • the friction enhancement 226 can include a plurality of bristles fixed to expanding device 224 engageable with the interior surface of the hollow member.
  • the friction enhancement 226 can include a plurality of loops fixed to the expanding member which engage the interior surface of the hollow member.
  • the friction enhancement 226 comprises a plurality of scales, suction cups, and/or ridges fixed to the expanding device 224 which engage with the interior surface of the hollow member.
  • fenestrated decoupling system 222 can be employed about friction enhancement 226 to encourage disengagement of friction enhancement 226 from interior surface 102 upon deflation of expanding device 224.
  • fenestrated decoupling system 222 can comprise a plurality of bands 228 being disposed longitudinally along friction enhancement 226 at radial positions radially thereabout.
  • the plurality of bands 228 are comprises of elastic bands, which can be made of a monofilament material.
  • the plurality of bands 228 can be retained by a pair of ring members 230 disposed at opposing sides of fenestrated attachment system 220 that permit the plurality of bands 228 to pass there over and be captured and retained within fenestrated attachment system 220.
  • fenestrated decoupling system 222 is operable to expand to accommodate inflation of expanding device 224 and, by association, enlarge friction enhancement 226, thereby permitting friction enhancement 226 to engage the interior surface 102 of hollow member 100.
  • extending mechanism 208 of elongation system 200 can be actuated.
  • expanding device 224 can be deflated and, by association, retract friction enhancement 226. This permits friction enhancement 226 to retract.
  • the plurality of bands 228 of fenestrated decoupling system 222 can similarly retract.
  • Retraction of friction enhancement 226 to a size smaller than retraction of the plurality of bands 228 of fenestrated decoupling system 222 can permit the plurality of bands 228 to disengage interior surface 102 of hollow member 100 from friction enhancement 226, thereby permitting insertion, removal, and purposeful repositioning of the device.
  • fenestrated decoupling system 222 can comprise a non-expanding device that is sufficiently fenestrated to permit expanding device 224 and friction enhancement 226 to extend through the fenestrated portions to a position exterior of fenestrated decoupling system 222 thereby engaging interior surface 102.
  • expanding device 224 and friction enhancement 226 can collapse within a volume defined by fenestrated decoupling system 222, thereby disengaging from interior surface 102.
  • atraumatic tip 12 is employed to provide progressive tapering or reduction in the amount of stiffness along at least a portion of the length of the device 10. More particularly, the stiffness of a proximal end 14 of atraumatic tip 12 that is adjacent an end of elongation system 200 and/or fenestrated attachment system 220 is generally greater than a distal end 16 of atraumatic tip 12. In some embodiments, this stiffness reduction along the length of atraumatic tip 12 can be linear, exponential, or define a non-linear predetermined reduction.
  • Atraumatic tip 12 can comprise one or more internal flexure members 18 and an optional covering or sheath 20 disposed about flexure members 18.
  • atraumatic tip 12 can comprise a 3.26-mm diameter stranded cable serving as flexure member 18 (8 AWG; [American wire gauge]; Southwire, Carrollton, GA), consisting of 19 strands of 0.72-mm diameter copper wire.
  • Each strand can be trimmed at 1 -cm intervals to decrease progressively the total strand count approaching the distal end 16, thereby decreasing progressively the stiffness.
  • the trimmed stranded cable can be inserted into a latex sheath or other covering 20 that is tapered gradually over a length of 33 cm from a 24-Fr base to an 8-Fr end.
  • the internal flexure member 18 can end at a distance less than the length of the covering 20, such as about 14 cm proximal to the end of the latex sheath 20.
  • the total length of atraumatic tip 12 can be about 80 cm. These materials and dimensions were chosen such that the most rigid end (i.e. proximal end 14) of the atraumatic tip 12 (the fully stranded 8 AWG wire) was stiff relative to the bowel (i.e., if advanced 'as-is' into the small intestine via the stoma, it would eventually lead to a perforation).
  • the distal end 16 of atraumatic tip 12 was selected such that it was more flexible than the bowel itself (i.e., when an 8-Fr latex catheter was advanced "as-is" in to the small intestine, it would conform to the intestinal curvature as illustrated in FIG. 6).
  • a gradual transition in stiffness along the length of atraumatic tip 12 was found to be important. If stiffness of the device decreased abruptly at any point along the device, the intestine would drape acutely over this abrupt transition. This "tip-effect" resulted in a disproportionate amount of longitudinal distractive force being applied in a concentrated area of the bowel wall at that point of transition. In previous devices where such a tapered tip was not used, perforation occurred at the end of the device.
  • a clamp (FIG. 7) can be mounted on a 10-cm wide rubber base, which can be sutured to the abdominal wall at the stoma site. After each advancement of the device, this clamp can be applied to provide proximal fixation of the device at the level of the stoma.
  • the bending stiffness of atraumatic tip 12 was measured along the length of its tapered portion. Bending stiffness is defined as the ratio between an applied bending moment, measured in N-m (Newtonsmeter), and the resulting curvature (reciprocal of the radius of curvature, or 1 /m) with resulting units of N-m2. Measurements of bending stiffness were performed by measuring the linear stiffness of a cantilevered section of atraumatic tip 12 (FIG. 8).
  • the atraumatic tip 12 was fixed horizontally in a V-groove clamp at a specified point along its length, and a series of weights (varying between 0.186 g and 250 g) were hung from a thread tied at a set test length distance (ranging from 15 to 50 mm) from the clamp.
  • the vertical deflection was measured as a function of load, where, according to classical linear beam theory, the bending stiffness is equal to one third times the test length cubed times the ratio between the applied load and the tip deflection.
  • the resulting bending stiffness ranged from a maximum of 1 .89 x 10 "2 Nm 2 at the proximal end of atraumatic tip 12 to 1 .5 x 10 "5 Nm 2 at the distal end (FIG. 9).
  • This radius relates to the largest amount of bending moment atraumatic tip 12 can apply to the bowel before atraumatic tip 12 takes a permanent "pose,” conforming to the bowel, after which the residual force on the bowel takes on a maximum at the value required to bend atraumatic tip 12 into that pose.
  • Atraumatic tip 12 was tested using a swine model for distraction enterogenesis.
  • atraumatic tip 12 was placed via a proximal jejunostomy.
  • a Roux limb was created 90 cm distal to the ligament of Treitz and the proximal end was brought out as a jejunostomy in the left abdomen.
  • the jejunostomy was secured in 3 layers at the skin, anterior fascia, and posterior fascia to prevent stoma retraction during distraction.
  • An end-to-side anastomosis was created to form a Roux-en-Y jejuno-jejunostomy to restore intestinal continuity.
  • the mesenteric defect was closed to prevent internal hernia.
  • the clamp mount was sutured circumferentially to the abdominal wall at the stoma site.
  • Device 10 was inserted via the stoma into the Roux limb, advancing atraumatic tip 12 first.
  • a 12-cm segment was selected 10 cm distal to the jejuno-jejunostomy to serve as a fed control and was marked similarly at 3-cm intervals, which allowed paired analysis of lengthening between the distracted and fed control segment from each animal. Separate control sham operations were not performed. The abdomen was then closed in standard fashion. All animals were fed a regular solid diet beginning on the first postoperative day until device explant.
  • atraumatic tip 12 was advanced 1 cm/day by unclamping the stoma clamp to release the catheter, manually advancing the catheter 1 cm, and reapplying the stoma clamp.
  • the distracted segment achieved a significant increase in length versus the fed, nondistracted bowel, without evidence of ischemia or perforation (see FIG. 1 1 ).
  • Bowel lengthening was noted from the stoma to the end of the device, which was initially placed to marker 12 (i.e., initially 3-cm intervals, for a total of 36 cm deep to the stoma).
  • the distance between markers along the distracted segment increased relative to the spacing of markers on the fed control segment.
  • the cumulative percent net lengthening of the bowel in contact with the device relative to fed control was 37 ⁇ 6% after 7 days, and 80 ⁇ 2% after 14 days of distraction (see FIG. 12).
  • the net gain in length was dependent on the length of bowel with which the device interacted.
  • the cumulative distance from the stoma to each bowel marker along the distracted segment was measured and compared to a group of control segment marker intervals at explant, extrapolated over the same number of markers (see FIG. 13).
  • the gain in length of the entire distracted segment relative to the fed control segment was 10.6 ⁇ 1 .7 cm after 7 days, corresponding to an average lengthening rate of 1 .5 ⁇ 0.2 cm/day.
  • Doubling the duration of distraction to 14 days resulted in additional lengthening, with a net gain of 16.8 ⁇ 3.0 cm, and a slight decrease in daily gain to 1 .2 ⁇ 0.2 cm/day.
  • the rate of lengthening consistently exceeded the 1 .0 cm/day advancement of the device. This change in length is consistent with prior methods of distraction enterogenesis, where bowel lengthening exceeded device expansion.
  • Clinically applicable distraction enterogenesis requires maximizing bowel length gain while minimizing the morbidity of the distraction therapy.
  • a fully endoluminal device may achieve this goal by allowing distraction without multiple operations.
  • the present teachings demonstrate a method of and apparatus for endoluminal distraction enterogenesis using an indwelling, semirigid device with an atraumatic geometry of the end of the device. This strategy provides an effective method of intestinal attachment via geometric coupling of the device and mesenteric curvature. In addition, this geometry may improve the safety profile of any endoluminal device that is stiff relative to the bowel. Because the small intestine is nonlinear in orientation with the mesentery tethering the bowel in a curved course, an endoluminal device must conform to this curvilinear shape.
  • This method of distraction enterogenesis required an enterostomy for device insertion.
  • Trans-stomal distraction enterogenesis has been described, although this technique relied on end-abutment of a stiff device on a surgically created intestinal blind end. Although such anatomy is not encountered frequently clinically, enterostomies and/or mucus fistulae often are present in patients with SBS.
  • Trans-stomal distraction enterogenesis using geometric attachment may be a viable method of increasing residual bowel length in these patients.
  • a device may be placed for a course of distraction therapy before takedown of the enterostomy in a patient who has undergone massive bowel resection and is at risk of SBS.
  • This approach may allow the reversal of disuse atrophy if used via a mucous fistula, may induce substantial gain of length before takedown of the enterostomy with reanastomosis, and would not require additional operative maneuvers.
  • This device achieved lengthening rates that compared favorably to serial transverse enteroplasty (STEP) outcomes. Seven days of distraction produced 37 ⁇ 6% lengthening versus nondistracted fed bowel. This is similar to the current standard of care for patients with medically refractory SBS, the primary STEP procedure, which has been reported to produce a 22-43% increase in bowel length. It is important to note, however, that STEP results are measured at a single operative setting, while distraction enterogenesis requires interval measurement of lengthening after a set distraction period. In addition, lengthening via distraction occurs only in the length of intestine that contacts the device, whereas enteroplasty may be employed throughout the remaining bowel.
  • STEP serial transverse enteroplasty
  • the percent length gain of the full distracted segment demonstrated limited variance, with a standard deviation of ⁇ 10% after 7 and 14 days of distraction. It is notable, however, that the variance in lengthening was considerably greater along the length of the Roux limb, with percent lengthening ranging from 25% (marker 2) to 84% (marker 9) at different points along the bowel. However, after the 10th marker, all Roux limbs had completed their first mesenteric curvature, which may explain why the variance in lengthening outcomes decreased abruptly after this point.
  • the animal model used in this study had the advantage of being similar in size to the human equivalent of a 25- to 50-kg child with SBS; however, the model was limited by requiring a laparotomy for implantation.
  • This model differed from the envisioned clinical use, wherein creation of an enterostomy would be performed as indicated for the clinical scenario, and placement of the device via the stoma would be performed at a later time. In this model, however, the device was placed at the initial laparotomy in order to place bowel markers for measurement of lengthening outcomes. At the time of explant on either postoperative day 7 or 14, generalized formation of intraperitoneal adhesions had occurred.
  • markers may be replaced with serial contrast studies to measure the outcomes of enterogenesis.
  • Another limitation of the operative model used was the placement of the device into an unfed segment of the jejunal Roux limb.
  • the target patient population for distraction enterogenesis will be dependent on parenteral nutrition, it will be critical to demonstrate that a clinically applicable device can produce intestinal lengthening in nondiverted bowel without causing obstruction.
  • a segment of unfed intestine without distraction was used as a secondary control. This approach was not performed in this study, because the device occupied the length of the Roux limb.
  • distracted bowel was unfed, while the control bowel was fed. Therefore, it is possible that distraction of the fed intestine may result in even greater gains in length in the future.
  • a potential limitation of the present teachings was the small number of animals that underwent device implantation. The lengthening outcomes of this approach were reproducible, with limited variation in percent length gain between animals. The consistent performance of this device allowed for the demonstration of substantial length gains, despite the limited number of animals.
  • trans-stomal distraction enterogenesis via geometric attachment was shown to be effective, this strategy may be applicable clinically in only select scenarios.
  • this device requires direct enteral access to the segment of intestine to be distracted.
  • the current approach would not be applicable via transgastric or trans-oral placement.
  • this method of intestinal coupling relies on the mesenteric curvature of the small bowel.
  • the remaining small intestine may not include a mesenteric curve to allow device attachment.
  • pre-existing adhesions may fix the bowel in a linear orientation, preventing geometric attachment.
  • Focal intestinal attachments where the specific site of device anchoring can be selected, may be preferable in these scenarios.
  • the present teachings demonstrated a transstomal endoluminal intestinal-lengthening device. Intestinal lengthening was achieved using a novel method of geometric device attachment, with outcomes comparable with operative lengthening. This attachment is an important component in the design of a device for treating patients with SBS.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)

Abstract

Un dispositif à demeure pour l'insertion dans une structure tubulaire biologique comprenant un dispositif allongé comportant un corps et des extrémités opposées. Le corps a une rigidité à la flexion transversale à un axe longitudinal qui est supérieure à une rigidité de la structure tubulaire biologique. Une pointe atraumatique élément, comportant une extrémité proximale et une extrémité distale, s'étend depuis l'extrémité du dispositif allongé. L'extrémité proximale a une première rigidité de flexion transversale à un axe longitudinal et l'extrémité distale a une deuxième rigidité de flexion transversale à l'axe longitudinal, dans lequel la seconde rigidité étant inférieure à la première rigidité.
PCT/US2016/014688 2015-01-23 2016-01-25 Géométrie de pointe atraumatique pour des dispositifs à demeure WO2016118948A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP16740895.4A EP3247448A4 (fr) 2015-01-23 2016-01-25 Géométrie de pointe atraumatique pour des dispositifs à demeure

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562106859P 2015-01-23 2015-01-23
US62/106,859 2015-01-23
US14/718,175 US10159486B2 (en) 2014-05-21 2015-05-21 Fenestrated decoupling system for internal selective attachment to soft tissue organs
US14/718,175 2015-05-21

Publications (1)

Publication Number Publication Date
WO2016118948A1 true WO2016118948A1 (fr) 2016-07-28

Family

ID=56417862

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/014688 WO2016118948A1 (fr) 2015-01-23 2016-01-25 Géométrie de pointe atraumatique pour des dispositifs à demeure

Country Status (2)

Country Link
EP (1) EP3247448A4 (fr)
WO (1) WO2016118948A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3145418B1 (fr) * 2014-05-21 2019-04-03 The Regents of The University of Michigan Système de découplage à fenêtre pour fixation sélective interne à des organes à tissu mous

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991014395A1 (fr) 1990-03-19 1991-10-03 Target Therapeutics Fil de guidage a bout distal flexible
US5205830A (en) 1991-11-12 1993-04-27 Arrow International Investment Corporation Catheter assembly
US6702802B1 (en) * 1999-11-10 2004-03-09 Endovascular Technologies, Inc. Catheters with improved transition
US20060190024A1 (en) 2005-02-24 2006-08-24 Bei Nianjiong Recovery catheter apparatus and method
US20060212022A1 (en) 2005-03-21 2006-09-21 Boston Scientific Scimed,Inc. Tissue approximation device
US20070219466A1 (en) * 2006-01-06 2007-09-20 Tremulis W S Atraumatic Catheter Tip
US20080200839A1 (en) * 2007-02-15 2008-08-21 Vance Products Inc., D/B/A Cook Urological Dual stiffness wire guide
US20090264863A1 (en) 2008-04-22 2009-10-22 Medtronic Vascular, Inc. Articulating Tip Tetherless Catheter System
US7722560B2 (en) 2007-02-09 2010-05-25 The Regents Of The University Of Michigan Mechanical extension implants for short bowel syndrome
US20110224625A1 (en) 2010-03-11 2011-09-15 Flickinger William J Device for Intraluminal Drug Delivery
US20110295234A1 (en) 2009-12-07 2011-12-01 Cook Incorporated Offset soft tip with proposed tooling
US20120016342A1 (en) * 2009-02-12 2012-01-19 St. Georges Healthcare Nhs Trust Percutaneous Guidewire
US20120083820A1 (en) * 2009-04-22 2012-04-05 The Regents Of The University Of California Expandable distension device for hollow organ growth
US8268009B2 (en) 2007-02-09 2012-09-18 The Regents Of The University Of Michigan Mechanical extension implants for short bowel syndrome

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991014395A1 (fr) 1990-03-19 1991-10-03 Target Therapeutics Fil de guidage a bout distal flexible
US5205830A (en) 1991-11-12 1993-04-27 Arrow International Investment Corporation Catheter assembly
US6702802B1 (en) * 1999-11-10 2004-03-09 Endovascular Technologies, Inc. Catheters with improved transition
US20060190024A1 (en) 2005-02-24 2006-08-24 Bei Nianjiong Recovery catheter apparatus and method
US20060212022A1 (en) 2005-03-21 2006-09-21 Boston Scientific Scimed,Inc. Tissue approximation device
US20070219466A1 (en) * 2006-01-06 2007-09-20 Tremulis W S Atraumatic Catheter Tip
US7722560B2 (en) 2007-02-09 2010-05-25 The Regents Of The University Of Michigan Mechanical extension implants for short bowel syndrome
US8268009B2 (en) 2007-02-09 2012-09-18 The Regents Of The University Of Michigan Mechanical extension implants for short bowel syndrome
US20080200839A1 (en) * 2007-02-15 2008-08-21 Vance Products Inc., D/B/A Cook Urological Dual stiffness wire guide
US20090264863A1 (en) 2008-04-22 2009-10-22 Medtronic Vascular, Inc. Articulating Tip Tetherless Catheter System
US20120016342A1 (en) * 2009-02-12 2012-01-19 St. Georges Healthcare Nhs Trust Percutaneous Guidewire
US20120083820A1 (en) * 2009-04-22 2012-04-05 The Regents Of The University Of California Expandable distension device for hollow organ growth
US20110295234A1 (en) 2009-12-07 2011-12-01 Cook Incorporated Offset soft tip with proposed tooling
US20110224625A1 (en) 2010-03-11 2011-09-15 Flickinger William J Device for Intraluminal Drug Delivery

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3145418B1 (fr) * 2014-05-21 2019-04-03 The Regents of The University of Michigan Système de découplage à fenêtre pour fixation sélective interne à des organes à tissu mous

Also Published As

Publication number Publication date
EP3247448A4 (fr) 2019-09-18
EP3247448A1 (fr) 2017-11-29

Similar Documents

Publication Publication Date Title
US7585308B2 (en) Handle system and method for use in anastomotic procedures
EP2563295B1 (fr) Endoprothèse pour la réparation de fuites d'anastomose chirurgicale
EP2421483B1 (fr) Dispositif extensible de distension pour la croissance des organes creux
Demehri et al. Development of an endoluminal intestinal lengthening device using a geometric intestinal attachment approach
JP2021142324A (ja) デュアル組織壁係留機構を有するステント
JP2008515586A (ja) 前立腺治療ステント
US10080676B2 (en) Delivery devices and related methods of use
KR20190133719A (ko) 조직 퇴축을 위한 장치 및 방법
Shekherdimian et al. The feasibility of using an endoluminal device for intestinal lengthening
EP3302355B1 (fr) Dispositif de greffe d'endoprothèse présentant des éléments d'ancrage présentant des géométries réglables
US10117738B2 (en) Atraumatic tip geometry for indwelling devices
JP2022542464A (ja) ステントを固定するためのシステムおよび装置
US20160045302A1 (en) Method and apparatus for treating urethral stricture
US20120150193A1 (en) System and methods for hysteroscopic tubular ligation
EP3247448A1 (fr) Géométrie de pointe atraumatique pour des dispositifs à demeure
JP7043589B2 (ja) ステント
US10076644B2 (en) Method and apparatus for treating urethral stricture
US9877727B2 (en) Diverticulum treating device
US10159486B2 (en) Fenestrated decoupling system for internal selective attachment to soft tissue organs
CN109260576B (zh) 可自行脱落的胰管支架及置入装置
EP3145418B1 (fr) Système de découplage à fenêtre pour fixation sélective interne à des organes à tissu mous
CN105764452A (zh) 控制幽门尺寸
US20170027721A1 (en) Medical drainage devices and methods of use
ES2882082T3 (es) Parche de revestimiento de estómago con fijación central
EP2620129A2 (fr) Système d'introduction et de positionnement d'endoprothèse, en particulier une endoprothèse intestinale, et endoprothèse, en particulier endoprothèse intestinale

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16740895

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2016740895

Country of ref document: EP